BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19577568)

  • 1. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.
    Sinicrope FA; Rego RL; Ansell SM; Knutson KL; Foster NR; Sargent DJ
    Gastroenterology; 2009 Oct; 137(4):1270-9. PubMed ID: 19577568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas.
    Yoon HH; Orrock JM; Foster NR; Sargent DJ; Smyrk TC; Sinicrope FA
    PLoS One; 2012; 7(8):e42274. PubMed ID: 22879926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Number of Natural Killer Cells in the Largest Diameter Lymph Nodes Is Associated with the Number of Retrieved Lymph Nodes and Lymph Node Size, and Is an Independent Prognostic Factor in Patients with Stage II Colon Cancer.
    Okada K; Sadahiro S; Chan LF; Ogimi T; Miyakita H; Saito G; Tanaka A; Suzuki T
    Oncology; 2018; 95(5):288-296. PubMed ID: 30138925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
    Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
    Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of FOXP3+ T regulatory cells in colorectal cancer.
    Vlad C; Kubelac P; Fetica B; Vlad D; Irimie A; Achimas-Cadariu P
    J BUON; 2015; 20(1):114-9. PubMed ID: 25778305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.
    Suzuki K; Kadota K; Sima CS; Nitadori J; Rusch VW; Travis WD; Sadelain M; Adusumilli PS
    J Clin Oncol; 2013 Feb; 31(4):490-8. PubMed ID: 23269987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
    Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
    Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
    Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.
    O'Callaghan DS; Rexhepaj E; Gately K; Coate L; Delaney D; O'Donnell DM; Kay E; O'Connell F; Gallagher WM; O'Byrne KJ
    Eur Respir J; 2015 Dec; 46(6):1762-72. PubMed ID: 26541534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lymph node size and FOXP3+ regulatory T cells in node-negative colon cancer.
    Märkl B; Paul B; Schaller T; Kretsinger H; Kriening B; Schenkirsch G
    J Clin Pathol; 2017 May; 70(5):443-447. PubMed ID: 27879345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours.
    Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S
    Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
    Yip WK; Abdullah MA; Yusoff SM; Seow HF
    Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intertumoral Heterogeneity of CD3
    Yoon HH; Shi Q; Heying EN; Muranyi A; Bredno J; Ough F; Djalilvand A; Clements J; Bowermaster R; Liu WW; Barnes M; Alberts SR; Shanmugam K; Sinicrope FA
    Clin Cancer Res; 2019 Jan; 25(1):125-133. PubMed ID: 30301825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer.
    Xu W; Liu H; Song J; Fu HX; Qiu L; Zhang BF; Li HZ; Bai J; Zheng JN
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1845-52. PubMed ID: 24005418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer.
    Salama P; Stewart C; Forrest C; Platell C; Iacopetta B
    Cancer Immunol Immunother; 2012 Aug; 61(8):1183-90. PubMed ID: 22210551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective Trial.
    Flaherty DC; Jalas JR; Sim MS; Stojadinovic A; Protic M; Lee DJ; Bilchik AJ
    Ann Surg Oncol; 2018 May; 25(5):1374-1380. PubMed ID: 29532344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.
    Zingg U; Montani M; Frey DM; Dirnhofer S; Esterman AJ; Went P; Oertli D
    Eur J Surg Oncol; 2010 Jul; 36(7):670-7. PubMed ID: 20510571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
    Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
    Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J; Hedenfalk I; Hagerling C
    Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.